You are currently viewing Study Indicates that EPA and DHA Supplementation Reduces Heart Attacks

Study Indicates that EPA and DHA Supplementation Reduces Heart Attacks

science-daily-logo

Original Article Release Date: September 17, 2020

A new study provides the most comprehensive analysis of the role of omega-3 dosage on cardiovascular prevention to date. The meta-analysis, which is an in-depth review of 40 clinical trials, provides authoritative evidence for consuming more EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) omega-3 fats.

The research concludes that EPA and DHA omega-3 intake is associated with reduced risk of coronary heart disease (CHD) events, the cause of 7.4 million deaths globally each year, and reduced risk of myocardial infarction (heart attack), including fatal heart attack.

Specifically, the study found that EPA+DHA supplementation is associated with a statistically significant reduced risk of:

  • Fatal myocardial infarction (35 percent)
  • Myocardial infarction (13 percent)
  • CHD events (10 percent)
  • CHD mortality (9 percent)

Read Full Article on Science Daily

Recommended Omega-3 Fish Oil Supplements

Fortifeye Super
Omega-3 Fish Oil

Best value for Re-esterfied Triglyceride Form (rTg) Omega-3

Fortifeye Super
Omega-3 Max

The most concentrated and purified Omega 3 fish oils available

Fortifeye Super
Omega Sport Fish Oil

The purest most potent Re-esterfied Triglyceride Form (rTG) Omega 3 fish oils